<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Primary squamous cell carcinoma of the breast: A case report and review of the literature.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Primary squamous cell carcinoma of the breast: A case report and review of the literature." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869869/bin/fonc-12-1033084-g002.jpg"/> </div> <div class="text-side"> <h1>Primary squamous cell carcinoma of the breast: A case report and review of the literature.</h1> <p>The postoperative pathological examination with hematoxylin and eosin (HE) staining and immunohistochemical (IHC) staining of the tumor. (A, B) Microscopically, the ductal cells in the mammary tumor area showed squamous degeneration and the lymph nodes were invaded by tumor cells (20x). (C, D) Histological findings with HE staining showed that the chest wall tumor was a moderately differentiated squamous cell carcinoma and the bone tissue was invaded by tumor cells(20x). (E) Histological findings with HE staining showed that the lung tumor was a metaplastic squamous cell carcinoma(20x). (F–I) IHC staining of the primary tumor in 2015. (F) ER negativity (20×). (G) PR negativity (20×). (H) HER2 receptor negativity (20×). (I) EGFR positive expression (20×). (J) IHC staining of the lung tumor showed that the PD-L1 positive.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36698422/" target="_blank">36698422</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>